JENNIFER BOOTH: Open Payments
NPI 1003540188 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,479 in 122 payments from 21 companies in 2025. Trend: 2023 $505 · 2024 $4,077 · 2025 $3,479
Food & beverage: $3,062Consulting: $250Education: $167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $640 |
| LEO Pharma Inc. | 15 | $418 |
| Regeneron Healthcare Solutions, Inc. | 14 | $281 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $280 |
| Arcutis Biotherapeutics, Inc. | 5 | $250 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $250 |
| Incyte Corporation | 8 | $245 |
| Janssen Biotech, Inc. | 7 | $245 |
| Galderma Laboratories, L.P. | 6 | $226 |
| GENZYME CORPORATION | 4 | $161 |
Products named: SKYRIZI, DUPIXENT, Zoryve, Neo-Synalar, OPZELURA, TREMFYA, ADBRY, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
